Effectiveness of Rebound Therapy in Parkinson's Patients

Effectiveness of Rebound Therapy on Balance and Gait in Parkinson's Patients

Today, physiotherapy approaches in Parkinson's Disease (PD) form the basis of optimal treatment together with medical and surgical treatment. It is stated that various rehabilitation interventions may be effective in the field of physiotherapy. The frequently preferred among these rehabilitation interventions is the conventional treatment approach. In the conventional treatment, various exercises are preferred to improve balance and walking, as well as stretching and strengthening. On the other hand, rebound therapy require strong integration of the neuromuscular system and provide more active use of lower extremity muscle strength. Rebound therapy have been shown to be effective in improving balance in many neurological disease groups, but there is very little study on rebound therapy in PD. It was shown that rebound therapy improve proprioceptive sense, joint range of motion and quality of life. On the other hand, no study has been found showing its effect on balance and walking. Therefore, there is a need to investigate the effectiveness of rebound therapy on balance and walking.

Study Overview

• Status: Completed
• Conditions: Parkinson Disease
• Intervention / Treatment: Other: Exercises on a stable surface; Other: Rebound therapy

Detailed Description

This study is a randomized controlled study. The patients will be randomly divided into two groups as rebound and control. The rebound group will perform exercises on a trampoline, consisting of 15 minutes of trunk and extremity stretching, 10 minutes of walking, and approximately 30 minutes of task-oriented exercises, twice a week for six weeks. While the control group will follow the same program as the rebound group, they will only perform task-oriented exercises on a stable surface, unlike the rebound group. As the outcome measures, disease severity and disability, balance, and gait performance will be evaluated.

• Study Type: Interventional
• Enrollment (Actual): 17
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Turkey
  • Sivas, Turkey
    • Sivas Cumhuriyet University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• 40-80 years of age
• Having diagnosed with "Parkinson's Disease" by a specialist physician
• Having between 1-3 stages according to the Hoehn and Yahr Scale
• Mini-Mental Test score more than or equal 24

Exclusion Criteria:

- Any orthopedic, vision, hearing, cardiovascular, or perception problems that may affect the research results

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Double

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Control group; The group that will perform exercises on a stable surface.	Other: Exercises on a stable surface; Participants will receive exercise-based training on a stable surface
Experimental: Rebound therapy; The group that will perform exercises on a trampoline.	Other: Rebound therapy; Participants will receive exercise-based training on a trampoline

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Static Balance- Baseline	Assessment will be made with the Biodex Balance System	Assessment will be conducted before the intervention
Static Balance- Post intervention	Assessment will be made with the Biodex Balance System	Assessment will be conducted immediately after the intervention
Gait speed- Baseline	Assessment will be made with the BTS G-Walk, (BTS SpA, Via della Croce Rossa, 11 Padova, Italy; SN: 0213-0378) during gait	Assessment will be conducted before the intervention
Gait speed- Post intervention	Assessment will be made with the BTS G-Walk, (BTS SpA, Via della Croce Rossa, 11 Padova, Italy; SN: 0213-0378) during gait	Assessment will be conducted immediately after the intervention
Knee strength- Baseline	Assessment will be made with an isokinetic dynamometer (Cybex Humac Norm Testing and Rehabilitation System, CSMI, USA)	Assessment will be conducted before the intervention
Knee strength-Post intervention	Assessment will be made with an isokinetic dynamometer (Cybex Humac Norm Testing and Rehabilitation System, CSMI, USA)	Assessment will be conducted immediately after the intervention

Collaborators and Investigators

• Sponsor: Gazi University

Publications and helpful links

General Publications

• Daneshvar P, Ghasemi G, Zolaktaf V, Karimi MT. Comparison of the Effect of 8-Week Rebound Therapy-Based Exercise Program and Weight-Supported Exercises on the Range of Motion, Proprioception, and the Quality of Life in Patients with Parkinson's Disease. Int J Prev Med. 2019 Aug 12;10:131. doi: 10.4103/ijpvm.IJPVM_527_18. eCollection 2019.

Study record dates

Study Major Dates

• Study Start (Actual): April 10, 2023
• Primary Completion (Actual): November 10, 2023
• Study Completion (Actual): December 10, 2023

Study Registration Dates

• First Submitted: May 3, 2023
• First Submitted That Met QC Criteria: May 3, 2023
• First Posted (Actual): May 11, 2023

Study Record Updates

• Last Update Posted (Actual): December 28, 2023
• Last Update Submitted That Met QC Criteria: December 20, 2023
• Last Verified: December 1, 2023

More Information

Terms related to this study

• Keywords: Parkinson's disease; task oriented training; balance and walking performance; rebound therapy
• Additional Relevant MeSH Terms: Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Parkinsonian Disorders; Basal Ganglia Diseases; Movement Disorders; Synucleinopathies; Neurodegenerative Diseases; Parkinson Disease
• Other Study ID Numbers: 5-PD-Rebound therapy-RCT

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: There is no plan to make PD data but when the statistical analysis of all data is made, all results will be shared.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No